News The benefit-risk of the mRNA-1273 COVID-19 vaccine By December 12, 202236 views ShareTweet 0 Glass laboratory flasks on light table Researchers modeled the benefit-risk of Moderna’s COVID-19 mRNA-1273 vaccine.
Reducing sugar content and package size of sodas may help reduce collective sugar intake By 14 hours ago0
Cryo-EM provides structural insights into a specific protein involved in Hailey-Hailey disease By 1 day ago0
Blacks and low-income Americans may reap the most benefits from stronger rules for air pollution 1 day ago0
Researchers secure $7.5 mllion from NIH HEAL initiative to tackle opioid and pain public health crises 1 day ago0
By 
Comments